We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MedAlliance Drug-Eluting Balloon Gets Conditional IDE for Coronary Lesions
MedAlliance Drug-Eluting Balloon Gets Conditional IDE for Coronary Lesions
MedAlliance announced that its Selution SLR drug-eluting balloon (DEB) has gained a conditional FDA investigational drug exemption (IDE) for the treatment of coronary de novo lesions, which typically have been treated with stents.